Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$71,843,464
+$35,372,744 QoQ
Shares Held
59,898
+51.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#453
of 4,605 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $1,720,661,138 across 10 Drug Manufacturers - General names. LLY ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
7,995,711 | $460,712,867 | |
| 2 | PFE |
Pfizer Inc
|
16,793,903 | $404,397,184 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,110,000 | $392,917,400 | |
| 4 | BIIB |
Biogen Inc.
|
1,122,981 | $242,631,274 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
59,898 | $71,843,464 | |
| 6 | ABBV |
AbbVie Inc.
|
201,334 | $50,663,687 | |
| 7 | JNJ |
Johnson & Johnson
|
183,172 | $46,520,192 | |
| 8 | AMGN |
Amgen Inc
|
74,159 | $26,854,457 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,843,464 | 59,898 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $36,470,720 | 39,652 | Shares | Sole | 2026-06-18 | |
| 2025-09-30 | $48,722,891 | 63,857 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $49,550,044 | 63,564 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $33,240,399 | 40,247 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $48,429,876 | 62,733 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $52,092,386 | 58,799 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $61,581,231 | 68,017 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $50,025,939 | 64,304 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $45,529,549 | 78,106 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $35,021,950 | 65,202 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $29,017,199 | 61,873 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $20,247,699 | 58,959 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,017,766 | 2,782 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,129,461 | 3,493 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $1,046,938 | 3,229 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,693,346 | 40,833 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $14,167,047 | 51,289 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $11,288,871 | 48,859 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $10,742,683 | 46,805 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $8,149,275 | 43,621 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $8,325,500 | 49,310 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $8,924,717 | 60,294 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $12,225,171 | 74,462 | Shares | Sole | 2020-07-29 | |
| No filing history on record for this holder in this stock. | ||||||